These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28643745)

  • 41. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity.
    Vassilis K; Ioannis G; Anna Z; Christina A; Christos A; John K; Porfyrios K; Vassiliki G; John K
    Breast Cancer; 2017 Mar; 24(2):263-270. PubMed ID: 27093861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Forward-planned, multiple-segment, tangential fields with concomitant boost in the treatment of breast cancer.
    Mayo C; Lo YC; Fitzgerald TJ; Urie M
    Med Dosim; 2004; 29(4):265-70. PubMed ID: 15528068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
    Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
    Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes.
    Fujii O; Hiratsuka J; Nagase N; Tokiya R; Yoden E; Sonoo H; Murashima N; Iha S; Imajyo Y
    Breast Cancer; 2008; 15(1):86-92. PubMed ID: 18224401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of electron beam treatment in postoperative management of carcinoma of the breast.
    Vishwanathan N; Bhaskar N; Supe SS; Swamy K; Ravichandran R; Kannan V; Ramesh C
    Indian J Cancer; 1998 Mar; 35(1):1-9. PubMed ID: 9847464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
    Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer.
    Tjessem KH; Johansen S; Malinen E; Reinertsen KV; Danielsen T; Fosså SD; Fosså A
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):337-43. PubMed ID: 23886416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer.
    Kyrgias G; Zygogianni A; Theodorou K; Koukourakis M; Oikonomou A; Kouvaris J; Kouloulias V
    Am J Clin Oncol; 2015 Aug; 38(4):358-63. PubMed ID: 23934132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined photon-electron beams in the treatment of the supraclavicular lymph nodes in breast cancer: A novel technique that achieves adequate coverage while reducing lung dose.
    Salem A; Mohamad I; Dayyat A; Kanaa'n H; Sarhan N; Roujob I; Salem AF; Afifi S; Jaradat I; Mubiden R; Almousa A
    Med Dosim; 2015; 40(3):210-7. PubMed ID: 25595492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial.
    Yadav BS; Dahiya D; Gupta M; Gupta A; Oinam AS; Khare S; Irrinki S; Robert N; Sakaray YR; Nagaraj SS; Kumari R
    Lancet Reg Health Southeast Asia; 2024 May; 24():100392. PubMed ID: 38550605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypofractionation should be the new 'standard' for radiation therapy after breast conserving surgery.
    Holloway CL; Panet-Raymond V; Olivotto I
    Breast; 2010 Jun; 19(3):163-7. PubMed ID: 20511064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radical chest wall resection and hyperfractionated accelerated radiotherapy for radiation-associated angiosarcoma of the breast: A safe and effective treatment strategy.
    Donovan EK; Corbett T; Vansantvoort J; Kak I; Popvic S; Heller B
    Breast J; 2018 May; 24(3):245-252. PubMed ID: 28845531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
    Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of pulmonary fibrosis after radiotherapy (RT) in breast conserving surgery: comparison between conventional external beam RT (EBRT) and intraoperative RT with electrons (ELIOT).
    Rampinelli C; Bellomi M; Ivaldi GB; Intra M; Raimondi S; Meroni S; Orecchia R; Veronesi U
    Technol Cancer Res Treat; 2011 Aug; 10(4):323-9. PubMed ID: 21728389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era.
    Damast S; Ho AY; Montgomery L; Fornier MN; Ishill N; Elkin E; Beal K; McCormick B
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1105-12. PubMed ID: 19879068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer.
    Saksornchai K; Rojpornpradit P; Shotelersak K; Lertbutsayanukul C; Chakkabat C; Raiyawa T
    J Med Assoc Thai; 2012 Feb; 95(2):229-40. PubMed ID: 22435254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of toxicities and outcomes in patients with breast cancer treated with hypofractionated radiotherapy.
    Sindhu M; Malik M; Ahmed SF; Valiyaveettil D
    Indian J Cancer; 2020; 57(4):423-427. PubMed ID: 33078749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.